Cancer Tumor

Cancer Tumor Article

Information resource about cancer clinical trials Melanoma Clinical Trials Listing Patients who participate in clinical trials and are among the first to melanoma treatments currently available have been tested in clinical Melanoma Clinical Trials Trial Title Condition Location Melanoma Clinical Trials Cancer Information Cancer Center Home Cancer Care and Prevention Professionals Melanoma Trials All Cancer Clinical Trials Urological Cancer Clincal Trials Lung Cancer Lymphoma Melanoma Pediatric Cancers Prostate Cancer All cancer types The clinical trials conducted by the National Cancer Institute (NCI) on the NIH Discusses what you need to know about melanoma, including clinical trials, coping, symptoms, and prevention Also offers an interactive tutorialIncludes information on selfexamination and symptoms, prevention, therapy, and moreDescription of melanoma through an explanation of the signs and symptoms, Melanoma Death Rate Still Climbing Gene Therapy Halts Skin Cancer Information about melanoma from the American Academy of Family Physicians and Management of Malignant Melanoma (American Family Physician April 1, Get PrinterFriendly Document: Why You Should Know About Melanoma What You Need To Know About Melanoma What You Need to Know about Melanoma Clinical Trials In active followup Melanoma Clinical Trials In active followup Melanoma Clinical Trials melanoma clinical trials at the NIH Clinical Center in Bethesda, Md NCI accepts referrals to melanoma clinical trials a list of melanoma clinical trials a list of melanoma clinical trials at the NIH Clinical Center in Bethesda, Md NCI accepts referrals to melanoma clinical

Cancer Tumor News

Tumor markers: testing for cancer.

Our ability to decrease the number of deaths caused by cancer depends, in part, on early detection and treatment. Learn what the major tumor markers are, how to evaluate their effectiveness, and what their role is in detection, diagnosis, and disease management. WE ALL LIVE IN the shadow of the big

Vaccine Shrinks Tumors In Kidney Cancer Study; Immunotherapy Success Triggers More Research

An experimental cancer vaccine, made by fusing a patient's tumor cells with specialized cells of the immune system, has produced dramatic shrinkage of tumors in a small study of patients with advanced kidney cancer, researchers reported yesterday. Although the results need to be confirmed in larger

Publication in Clinical Cancer Research Confirms Ability of Peregrine's Bavituximab to Target Tumor Blood Vessels with Excellent Specificity.

- Data Further Supports High Degree of Tumor Targeting Specificity for Bavituximab, Currently in Phase II Cancer Trials in Combination with Chemotherapy - - Imaging Study Also Suggests Potential Utility of Anti-PS Agents for Molecular Imaging of Tumors - TUSTIN, Calif., March 3

Tumor Size Predicts Survival In Patients With Lung Cancer; Study Shows Need For Further Substaging In Lung Cancer.

NORTHBROOK, Ill., Nov. 10 /PRNewswire/ - Tumor size is an important predictor of survival in patients with early-stage lung cancer, says a study published in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP). The study shows that patients

TECHNICLONE: Techniclone expands solid tumor brain cancer study to include UCLA.

M2 PRESSWIRE-21 June 1999-TECHNICLONE: Techniclone expands solid tumor brain cancer study to include UCLA (C)1994-99 M2 COMMUNICATIONS LTD RDATE:210699 TUSTIN, CA - Techniclone Corporation (NASDAQ: TCLN), a developer of leading-edge unique therapeutics for the advanced treatment of cancer,